EcoDrugPlus

Mitogen-Activated Protein Kinase Kinase Kinase 5

Ensembl ID : ENSCHAG00000005682
Gene Symbol: MAP3K5
3 Cross references
205 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 9

Ensembl ID : ENSCHAG00000023050
Gene Symbol: MAP3K9
1 Cross references
196 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSCHAG00000018000
Gene Symbol: MGLL
1 Cross references
209 Possible Orthologues:

Motilin Receptor

Ensembl ID : ENSCHAG00000020968
Gene Symbol: MLNR
3 Cross references
172 Possible Orthologues:

Muscarinic Acetylcholine Receptor M5-Like

Ensembl ID : ENSCHAG00000017428
Gene Symbol: LOC105899398
3 Cross references
190 Possible Orthologues:

Natriuretic Peptide Receptor 1a

Ensembl ID : ENSCHAG00000004202
Gene Symbol: NPR1A
1 Cross references
196 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSCHAG00000001537
Gene Symbol: NPR2
3 Cross references
191 Possible Orthologues:

Neuromedin-K Receptor-Like

Ensembl ID : ENSCHAG00000015499
Gene Symbol: LOC105902162
3 Cross references
197 Possible Orthologues:

Neuromedin-K Receptor-Like

Ensembl ID : ENSCHAG00000011038
Gene Symbol: LOC105891416
2 Cross references
130 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-2-Like

Ensembl ID : ENSCHAG00000001170
Gene Symbol: LOC105906770
3 Cross references
192 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSCHAG00000019622
Gene Symbol: NPY2R
3 Cross references
183 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSCHAG00000014915
Gene Symbol: NTSR1
1 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).